Management of rheumatoid arthritis
Identifieur interne : 003426 ( Main/Exploration ); précédent : 003425; suivant : 003427Management of rheumatoid arthritis
Auteurs : Carin E. Dugowson ; Bruce C. GillilandSource :
- Disease-a-Month [ 0011-5029 ] ; 1986.
Descripteurs français
- KwdFr :
- Anti-inflammatoires (effets indésirables), Anti-inflammatoires (usage thérapeutique), Arthrite juvénile (physiopathologie), Association de médicaments, Azathioprine (usage thérapeutique), Chloroquine (usage thérapeutique), Cyclophosphamide (usage thérapeutique), Humains, Hydroxychloroquine (usage thérapeutique), Immunosuppresseurs (usage thérapeutique), Leucaphérèse, Maladies du rachis (), Maladies pulmonaires (), Méthotrexate (usage thérapeutique), Or (usage thérapeutique), Plasmaphérèse, Polyarthrite rhumatoïde (), Polyarthrite rhumatoïde (anatomopathologie), Polyarthrite rhumatoïde (étiologie), Pénicillamine (usage thérapeutique), Radiothérapie, Rhumatismes (traitement médicamenteux), Salicylates (usage thérapeutique), Syndrome de Felty (traitement médicamenteux), Syndrome de Gougerot-Sjögren (traitement médicamenteux), Tissu lymphoïde (effets des radiations), Vascularite (traitement médicamenteux).
- MESH :
- anatomopathologie : Polyarthrite rhumatoïde.
- effets des radiations : Tissu lymphoïde.
- effets indésirables : Anti-inflammatoires.
- physiopathologie : Arthrite juvénile.
- traitement médicamenteux : Rhumatismes, Syndrome de Felty, Syndrome de Gougerot-Sjögren, Vascularite.
- usage thérapeutique : Anti-inflammatoires, Azathioprine, Chloroquine, Cyclophosphamide, Hydroxychloroquine, Immunosuppresseurs, Méthotrexate, Or, Pénicillamine, Salicylates.
- étiologie : Polyarthrite rhumatoïde.
- Association de médicaments, Humains, Leucaphérèse, Maladies du rachis, Maladies pulmonaires, Plasmaphérèse, Polyarthrite rhumatoïde, Radiothérapie.
English descriptors
- KwdEn :
- Anti-Inflammatory Agents (adverse effects), Anti-Inflammatory Agents (therapeutic use), Arthritis, Juvenile (physiopathology), Arthritis, Rheumatoid (complications), Arthritis, Rheumatoid (etiology), Arthritis, Rheumatoid (pathology), Arthritis, Rheumatoid (therapy), Azathioprine (therapeutic use), Chloroquine (therapeutic use), Cyclophosphamide (therapeutic use), Drug Therapy, Combination, Felty Syndrome (drug therapy), Gold (therapeutic use), Humans, Hydroxychloroquine (therapeutic use), Immunosuppressive Agents (therapeutic use), Leukapheresis, Lung Diseases (complications), Lymphoid Tissue (radiation effects), Methotrexate (therapeutic use), Penicillamine (therapeutic use), Plasmapheresis, Radiotherapy, Rheumatic Diseases (drug therapy), Salicylates (therapeutic use), Sjogren's Syndrome (drug therapy), Spinal Diseases (complications), Vasculitis (drug therapy).
- MESH :
- chemical , adverse effects : Anti-Inflammatory Agents.
- chemical , therapeutic use : Anti-Inflammatory Agents, Azathioprine, Chloroquine, Cyclophosphamide, Gold, Hydroxychloroquine, Immunosuppressive Agents, Methotrexate, Penicillamine, Salicylates.
- complications : Arthritis, Rheumatoid, Lung Diseases, Spinal Diseases.
- drug therapy : Felty Syndrome, Rheumatic Diseases, Sjogren's Syndrome, Vasculitis.
- etiology : Arthritis, Rheumatoid.
- pathology : Arthritis, Rheumatoid.
- physiopathology : Arthritis, Juvenile.
- radiation effects : Lymphoid Tissue.
- therapy : Arthritis, Rheumatoid.
- Teeft :
- Abnormality, Analgesic, Antimalarial, Arachidonic, Arachidonic acid, Arthritis, Arthritis rheum, Aspirin, Auranofin, Azathioprine, Carpal, Carpal tunnel syndrome, Chloroquine, Clin, Clinical response, Cyclophosphamide, Cytotoxic, Daily dose, Dos, Drug Therapy, Combination, Effusion, Engl, Glucocorticoid, Gold salts, Gold therapy, High doses, Humans, Hydroxychloroquine, Ibuprofen, Indomethacin, Inflammation, Inflammatory, Leukapheresis, Leukotrienes, Liver function tests, Lymphocyte, Lymphoid, Medication, Methotrexate, Nephrotic syndrome, Neutrophil, Nodule, Nonsteroidal, Nonsteroidal drugs, Nsaid, Osteopenia, Peak plasma levels, Penicillamine, Phenylbutazone, Piroxicam, Placebo, Plasmapheresis, Platelet, Platelet count, Prostaglandin, Prostaglandin synthesis, Prosthesis, Proteinuria, Radiotherapy, Rash, Regimen, Remittive, Remittive agent, Renal, Rheumatoid, Rheumatoid arthritis, Rheumatoid factor, Rheumatoid nodules, Rheumatoid patients, Rheumatoid vasculitis, Rheumatol, Rheumatology, Salicylate, Second course, Side effects, Splenectomy, Splint, Steroid, Sulindac, Syndrome, Synovectomy, Synovial, Synovitis, Synovium, Tendon, Therapeutic effectiveness, Therapy, Total lymphoid irradiation, Toxicity, Urine, Vasculitis, Warfarin sodium.
Url:
DOI: 10.1016/S0011-5029(86)80002-5
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000127
- to stream Istex, to step Curation: 000127
- to stream Istex, to step Checkpoint: 002185
- to stream Main, to step Merge: 003499
- to stream PubMed, to step Corpus: 000587
- to stream PubMed, to step Curation: 000587
- to stream PubMed, to step Checkpoint: 000557
- to stream Ncbi, to step Merge: 001055
- to stream Ncbi, to step Curation: 001055
- to stream Ncbi, to step Checkpoint: 001055
- to stream Main, to step Merge: 003436
- to stream Main, to step Curation: 003426
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of rheumatoid arthritis</title>
<author><name sortKey="Dugowson, Carin E" sort="Dugowson, Carin E" uniqKey="Dugowson C" first="Carin E." last="Dugowson">Carin E. Dugowson</name>
</author>
<author><name sortKey="Gilliland, Bruce C" sort="Gilliland, Bruce C" uniqKey="Gilliland B" first="Bruce C." last="Gilliland">Bruce C. Gilliland</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B7CD9023CA8C7B81F5203A5833A50BB6C625C078</idno>
<date when="1986" year="1986">1986</date>
<idno type="doi">10.1016/S0011-5029(86)80002-5</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-3D9Z23JV-Z/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000127</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000127</idno>
<idno type="wicri:Area/Istex/Curation">000127</idno>
<idno type="wicri:Area/Istex/Checkpoint">002185</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002185</idno>
<idno type="wicri:doubleKey">0011-5029:1986:Dugowson C:management:of:rheumatoid</idno>
<idno type="wicri:Area/Main/Merge">003499</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:3512214</idno>
<idno type="wicri:Area/PubMed/Corpus">000587</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000587</idno>
<idno type="wicri:Area/PubMed/Curation">000587</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000587</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000557</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000557</idno>
<idno type="wicri:Area/Ncbi/Merge">001055</idno>
<idno type="wicri:Area/Ncbi/Curation">001055</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001055</idno>
<idno type="wicri:doubleKey">0011-5029:1986:Dugowson C:management:of:rheumatoid</idno>
<idno type="wicri:Area/Main/Merge">003436</idno>
<idno type="wicri:Area/Main/Curation">003426</idno>
<idno type="wicri:Area/Main/Exploration">003426</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Management of rheumatoid arthritis</title>
<author><name sortKey="Dugowson, Carin E" sort="Dugowson, Carin E" uniqKey="Dugowson C" first="Carin E." last="Dugowson">Carin E. Dugowson</name>
</author>
<author><name sortKey="Gilliland, Bruce C" sort="Gilliland, Bruce C" uniqKey="Gilliland B" first="Bruce C." last="Gilliland">Bruce C. Gilliland</name>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Disease-a-Month</title>
<title level="j" type="abbrev">YMDA</title>
<idno type="ISSN">0011-5029</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1986">1986</date>
<biblScope unit="volume">32</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="1">1</biblScope>
<biblScope unit="page" to="74">74</biblScope>
</imprint>
<idno type="ISSN">0011-5029</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0011-5029</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Inflammatory Agents (adverse effects)</term>
<term>Anti-Inflammatory Agents (therapeutic use)</term>
<term>Arthritis, Juvenile (physiopathology)</term>
<term>Arthritis, Rheumatoid (complications)</term>
<term>Arthritis, Rheumatoid (etiology)</term>
<term>Arthritis, Rheumatoid (pathology)</term>
<term>Arthritis, Rheumatoid (therapy)</term>
<term>Azathioprine (therapeutic use)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Cyclophosphamide (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Felty Syndrome (drug therapy)</term>
<term>Gold (therapeutic use)</term>
<term>Humans</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Leukapheresis</term>
<term>Lung Diseases (complications)</term>
<term>Lymphoid Tissue (radiation effects)</term>
<term>Methotrexate (therapeutic use)</term>
<term>Penicillamine (therapeutic use)</term>
<term>Plasmapheresis</term>
<term>Radiotherapy</term>
<term>Rheumatic Diseases (drug therapy)</term>
<term>Salicylates (therapeutic use)</term>
<term>Sjogren's Syndrome (drug therapy)</term>
<term>Spinal Diseases (complications)</term>
<term>Vasculitis (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anti-inflammatoires (effets indésirables)</term>
<term>Anti-inflammatoires (usage thérapeutique)</term>
<term>Arthrite juvénile (physiopathologie)</term>
<term>Association de médicaments</term>
<term>Azathioprine (usage thérapeutique)</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Cyclophosphamide (usage thérapeutique)</term>
<term>Humains</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Leucaphérèse</term>
<term>Maladies du rachis ()</term>
<term>Maladies pulmonaires ()</term>
<term>Méthotrexate (usage thérapeutique)</term>
<term>Or (usage thérapeutique)</term>
<term>Plasmaphérèse</term>
<term>Polyarthrite rhumatoïde ()</term>
<term>Polyarthrite rhumatoïde (anatomopathologie)</term>
<term>Polyarthrite rhumatoïde (étiologie)</term>
<term>Pénicillamine (usage thérapeutique)</term>
<term>Radiothérapie</term>
<term>Rhumatismes (traitement médicamenteux)</term>
<term>Salicylates (usage thérapeutique)</term>
<term>Syndrome de Felty (traitement médicamenteux)</term>
<term>Syndrome de Gougerot-Sjögren (traitement médicamenteux)</term>
<term>Tissu lymphoïde (effets des radiations)</term>
<term>Vascularite (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Inflammatory Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term>
<term>Azathioprine</term>
<term>Chloroquine</term>
<term>Cyclophosphamide</term>
<term>Gold</term>
<term>Hydroxychloroquine</term>
<term>Immunosuppressive Agents</term>
<term>Methotrexate</term>
<term>Penicillamine</term>
<term>Salicylates</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Polyarthrite rhumatoïde</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Arthritis, Rheumatoid</term>
<term>Lung Diseases</term>
<term>Spinal Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Felty Syndrome</term>
<term>Rheumatic Diseases</term>
<term>Sjogren's Syndrome</term>
<term>Vasculitis</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Tissu lymphoïde</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anti-inflammatoires</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Arthritis, Rheumatoid</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arthritis, Rheumatoid</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Arthrite juvénile</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Arthritis, Juvenile</term>
</keywords>
<keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Lymphoid Tissue</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Arthritis, Rheumatoid</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Rhumatismes</term>
<term>Syndrome de Felty</term>
<term>Syndrome de Gougerot-Sjögren</term>
<term>Vascularite</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires</term>
<term>Azathioprine</term>
<term>Chloroquine</term>
<term>Cyclophosphamide</term>
<term>Hydroxychloroquine</term>
<term>Immunosuppresseurs</term>
<term>Méthotrexate</term>
<term>Or</term>
<term>Pénicillamine</term>
<term>Salicylates</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Polyarthrite rhumatoïde</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abnormality</term>
<term>Analgesic</term>
<term>Antimalarial</term>
<term>Arachidonic</term>
<term>Arachidonic acid</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Aspirin</term>
<term>Auranofin</term>
<term>Azathioprine</term>
<term>Carpal</term>
<term>Carpal tunnel syndrome</term>
<term>Chloroquine</term>
<term>Clin</term>
<term>Clinical response</term>
<term>Cyclophosphamide</term>
<term>Cytotoxic</term>
<term>Daily dose</term>
<term>Dos</term>
<term>Drug Therapy, Combination</term>
<term>Effusion</term>
<term>Engl</term>
<term>Glucocorticoid</term>
<term>Gold salts</term>
<term>Gold therapy</term>
<term>High doses</term>
<term>Humans</term>
<term>Hydroxychloroquine</term>
<term>Ibuprofen</term>
<term>Indomethacin</term>
<term>Inflammation</term>
<term>Inflammatory</term>
<term>Leukapheresis</term>
<term>Leukotrienes</term>
<term>Liver function tests</term>
<term>Lymphocyte</term>
<term>Lymphoid</term>
<term>Medication</term>
<term>Methotrexate</term>
<term>Nephrotic syndrome</term>
<term>Neutrophil</term>
<term>Nodule</term>
<term>Nonsteroidal</term>
<term>Nonsteroidal drugs</term>
<term>Nsaid</term>
<term>Osteopenia</term>
<term>Peak plasma levels</term>
<term>Penicillamine</term>
<term>Phenylbutazone</term>
<term>Piroxicam</term>
<term>Placebo</term>
<term>Plasmapheresis</term>
<term>Platelet</term>
<term>Platelet count</term>
<term>Prostaglandin</term>
<term>Prostaglandin synthesis</term>
<term>Prosthesis</term>
<term>Proteinuria</term>
<term>Radiotherapy</term>
<term>Rash</term>
<term>Regimen</term>
<term>Remittive</term>
<term>Remittive agent</term>
<term>Renal</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatoid factor</term>
<term>Rheumatoid nodules</term>
<term>Rheumatoid patients</term>
<term>Rheumatoid vasculitis</term>
<term>Rheumatol</term>
<term>Rheumatology</term>
<term>Salicylate</term>
<term>Second course</term>
<term>Side effects</term>
<term>Splenectomy</term>
<term>Splint</term>
<term>Steroid</term>
<term>Sulindac</term>
<term>Syndrome</term>
<term>Synovectomy</term>
<term>Synovial</term>
<term>Synovitis</term>
<term>Synovium</term>
<term>Tendon</term>
<term>Therapeutic effectiveness</term>
<term>Therapy</term>
<term>Total lymphoid irradiation</term>
<term>Toxicity</term>
<term>Urine</term>
<term>Vasculitis</term>
<term>Warfarin sodium</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term>
<term>Humains</term>
<term>Leucaphérèse</term>
<term>Maladies du rachis</term>
<term>Maladies pulmonaires</term>
<term>Plasmaphérèse</term>
<term>Polyarthrite rhumatoïde</term>
<term>Radiothérapie</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Dugowson, Carin E" sort="Dugowson, Carin E" uniqKey="Dugowson C" first="Carin E." last="Dugowson">Carin E. Dugowson</name>
<name sortKey="Gilliland, Bruce C" sort="Gilliland, Bruce C" uniqKey="Gilliland B" first="Bruce C." last="Gilliland">Bruce C. Gilliland</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003426 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003426 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:B7CD9023CA8C7B81F5203A5833A50BB6C625C078 |texte= Management of rheumatoid arthritis }}
This area was generated with Dilib version V0.6.33. |